INTERLEUKIN-28B GENE POLYMORHISM TEST ON HBV MAY BE VERY USEFULL
Title INTERLEUKIN-28B GENE POLYMORHISM MAY AFFECT THE NATURAL COURSE OF HEPATITIS B and DELTA VIRUS INFECTIONS
Speaker: A. Mithat Bozdayi
Author: A.M. Bozdayi1,2*, T. Ozturk1, S. Altuntas1, S.C. Karatayli1, E. Karatayli1, C. Inci1, K. Cinar2, R. Albayrak3, M. Ozkan3, Y. Kendal4, R. Idilman2, C. Yurdaydin1,2
Affiliation: 1Institute of Hepatology, 2Department of Gastroenterology School of Medicine, 3Biometry Genetics Department, Ankara University, Ankara, 4Department of Gastroenterology, Dicle University Faculty of Medicine, Diyarbakir, Turkey. *mithat.***@****
Background and aims: It has been suggested that interleukin-28B (IL-28B) polymorphisms are associated with spontaneous clearance of hepatitis C virus (HCV) and be a strong determinant of sustained virologic response in genotypes 1 to 3 HCV. Effect of IL28B polymorphism in treatment response to interferons and outcome in hepatitis B virus infection is much less investigated. The aim of the current study was to investigate a potential association between several single nucleotide polymorphisms (SNPs) of the IL-28B gene (rs12979860, rs1188122, rs8099917, rs8105790, rs12980275) and the natural course of HBV and hepatitis delta virus (HDV) infections.
Material-methods: The study included the following groups: group 1: 211 patients with HBV infection (49 inactive HBV carriers; 162 chronic HBV patients); group 2: 124 anti HBsAg positive persons and group 3: 103 patients with chronic HDV infection. DNA sequencing results were interpreted statistically with the chi-square test and the independent variables were determined by calculating the corresponding odds ratio (OR) and its 95% confidence interval (95% CI) by means of simple logistic regression.
Results: A significant difference (p< 0.01) between group 2 (anti-HBsAg positive) and group 3 (patients with HDV infection) for
(i) TT genotype of rs12979860
(ii) TG and GG genotypes of rs8099917 and
(iii) CC genotype of rs8105790. Significant differences (p< 0.01) were also detected between group 1 (patients with hepatitis B virus infection) and group 2 (anti-HBsAg positive) for
(i) GG genotype of rs8099917,
(ii) TT and TC genotypes of rs8105790. Interestingly, highly significant differences were observed within group 1 patients (patients with hepatitis B virus infection) between inactive HBV carriers and patients with chronic hepatitis B for
(i) TG and GG genotypes of rs8099917 (p< 0.0001) and
(ii) TT and TC genotypes of rs8105790 (p< 0.0001)
Conclusion: These results suggest that IL-28B polymorphisms may affect the natural history of HBV infection:
(i) it may be associated with the development of natural immunity;
(ii) it is a strong determinant of the inactive HBsAg carrier state;
(iii) it may affect progression to chronic B hepatitis following HBV infection; and
(iv) may also be involved in progression of HDV infection to chronicity.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.